Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters
Study flags need to monitor frailty risks with GLP-1 drugs for older adults Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
No locations linked to this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUU1ZX1Zfd0F3c1A5M0ZuNktDa3MzY0xMZklnTEN3cjdqam5CWWpTM2tHamp3YXhFMjVPSm43SlFweUk2R3RuS1FJa1A0WUFtSTNVUlYxWjdRb2RXSmczOW1fUDBkcTNPVWZlR29ocThIWnFpUnhCX09LYVVqLTFQc1RjRHI3WFlwYjIzVVU2aEhOa1JBRlNoV2pnVWRoTFM3YXJYYXFJcUhoYXZTd1ZpSmRwX3NKT05kM3Vqc3FR?oc=5" target="_blank">Study flags need to monitor frailty risks with GLP-1 drugs for older adults</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMRoche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
August 24, 2026 at 05:39 PMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
August 28, 2026 at 06:38 PMChina's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AM